8-K: VSee Health Secures $108,695.65 Convertible Note, Amends Agreements with Investors

VSee Health, Inc. has entered into a secured convertible promissory note agreement for $108,695.65 and amended existing agreements to adjust terms with its investors.

Summary

• VSee Health, Inc. has entered into a secured convertible promissory note agreement for $108,695.65 with an accredited investor.
• The note carries an 18% interest rate and matures on December 20, 2025.
• The company also issued 25,000 shares of its common stock to the investor.
• The note is convertible into shares of common stock at a price equal to the greater of $2.00 or the lower of (a) the lowest average historical Nasdaq Official Closing Price (NOCP) of a share of Common Stock as quoted on The Nasdaq Capital Market for the five trading days immediately preceding March 20, 2025 or (b) the Historical NOCP of Common Stock as quoted on The Nasdaq Capital Market on the day prior to March 20, 2025.
• The company amended its Securities Purchase Agreement (SPA) with another investor, issuing a senior secured note for $555,555.56 and 100,000 commitment shares.
• The senior secured note bears an interest rate of 5% per annum and will mature on November 1, 2025.
• The company also amended its Equity Purchase Agreement (EPA) with an investor, adjusting the floor price to $1.25, subject to adjustments for corporate actions.
• The Second Note is subordinated to the Note, the senior secured convertible note issued to the Investor on September 30, 2024 and the senior convertible promissory note with an aggregate principal value of $2,523,744.29 issued to an investor on June 24, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company is securing funding, it comes with debt and potential dilution. The amendments to existing agreements could be positive or negative depending on the specific terms and their impact on the company's financial flexibility.

Positives

• The company has secured additional funding through a convertible note.
• The company has amended existing agreements with investors, potentially improving terms or flexibility.
• The company has issued commitment shares to investors, which may incentivize their continued support.

Negatives

• The company is taking on debt, which could increase its financial risk.
• The company is issuing shares, which could dilute existing shareholders.
• The company is amending existing agreements, which could indicate that the original terms were not favorable.

Risks

• The company may not be able to repay the debt.
• The company's stock price may decline due to dilution.
• The company may not be able to meet the terms of the amended agreements.

Future Outlook

The company intends to use the proceeds from the note for general working capital. The company may need to raise additional capital in the future.

Industry Context

The document reflects common financing activities for growth-stage companies, including convertible notes and equity purchase agreements. The specific terms, such as interest rates and conversion prices, are influenced by the company's financial health, market conditions, and negotiation with investors.

Comparison to Industry Standards

• Convertible notes are a common financing tool for small to medium sized companies, especially in the tech and healthcare sectors, allowing them to raise capital without immediately diluting equity.
• Interest rates on convertible notes can vary widely depending on the perceived risk of the investment, but 18% is relatively high, suggesting the investor sees a higher risk profile for VSee Health.
• The use of a floor price in the Equity Purchase Agreement is a mechanism to protect the investor from significant downside risk in the company's stock price.
• Comparable companies in the telehealth space, such as Teladoc Health or Amwell, typically have access to more traditional financing options like bank loans or public equity offerings due to their larger scale and established market presence.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Employees may benefit from the company's increased financial stability.
• Customers may benefit from the company's ability to invest in its products and services.
• Creditors may be concerned about the company's increased debt load.

Next Steps

• The company needs to manage its debt obligations and ensure it can meet the terms of the agreements.
• The company needs to monitor its stock price and consider the potential impact of dilution.
• The company needs to use the proceeds from the note effectively to grow its business.

Key Dates

Keywords

convertible note, securities purchase agreement, equity purchase agreement, financing, common stock, investor, VSee Health